arrow
P

Panagiotis Baliakas

Uppsala University
H指数:31
被引数:3,228

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

更正:携带t(14;19)易位的慢性淋巴细胞白血病患者临床和转录组学特征:一项ERIC研究

Leukemia
IF13.4
2026-10-160
OAAI
Somatic RUNX1 exonic deletions in myelodysplastic syndrome: A rare yet high‐risk recurrent genetic aberration

骨髓增生异常综合征中体细胞RUNX1外显子缺失:一种罕见但高风险的复发遗传异常

2026-08-210
OAAI
Genomic Medicine Sweden: Advancing precision medicine at the national level

瑞典基因组医学:在国家层面推进精准医学

2026-07-280
OAAI
Clonal hematopoiesis of indeterminate potential in high grade B-cell lymphomas: clinicobiological associations and further insight with single-cell multiomics analysis

不确定潜力的克隆性造血在高级别B细胞淋巴瘤中的临床生物学关联及单细胞多组学分析带来的进一步见解

2026-06-200
OA
Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study

携带t(14;19)易位的慢性淋巴细胞白血病患者临床及转录组学特征:一项ERIC研究

Leukemia
IF13.4
2025-09-190
OAAI
MALNC: a new mutant NPM1/IDH2R140 and PML-RARA-associated lncRNA with impact on AML cell proliferation, maturation and drug response

MALNC:一种新的NPM1/IDH2R140和PML-RARA相关lncRNA突变体,对AML细胞增殖、成熟和药物反应具有影响

2025-08-230
OAAI
A national long-read sequencing study on chromosomal rearrangements uncovers hidden complexities
2024-10-291
PRE
How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms

如何管理种系DDX41变异患者: 来自骨髓肿瘤种系易感性北欧工作组的建议

2024-08-130
OAAI
Precision Diagnostics in Myeloid Malignancies: Development and Validation of a National Capture-Based Gene Panel
2024-07-190
OAAI
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL

慢性淋巴细胞白血病患者新型冠状病毒肺炎和COVID后病情的演变: 欧洲CLL研究计划ERIC的一项研究

2023-09-2911
OAAI